Skip to main content
PMC home page
Heart logoLink to Heart
. 1998 Sep;80(3):270–275. doi: 10.1136/hrt.80.3.270

Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection

G Dalekos 1, K Achenbach 1, D Christodoulou 1, G Liapi 1, E Zervou 1, D Sideris 1, E Tsianos 1
PMCID: PMC1761085  PMID: 9875087

Abstract

Objective—To determine whether there is an association between hepatitis C virus (HCV) infection and dilated cardiomyopathy in a well defined area of north western Greece; such an association has been reported elsewhere.
Design—Evaluation of consecutive patients with chronic HCV infection for the presence of clinical or subclinical manifestations of dilated cardiomyopathy by history, physical examination, and non-invasive laboratory procedures (ECG, chest x ray, and echocardiography) before the initiation of interferon α treatment; investigation for HCV infection markers in patients with dilated cardiomyopathy by enzyme and immunoblot assays (antibodies to HCV) and the reverse transcriptase polymerase chain reaction (HCV RNA).
Setting—A tertiary referral centre for patients with chronic hepatitis and dilated cardiomyopathy.
Patients—102 patients with well defined chronic HCV infection and 55 patients with well established dilated cardiomyopathy were evaluated.
Main outcome measures—The need for HCV testing in patients with dilated cardiomyopathy, or follow up for heart disease in patients with chronic HCV infection.
Results—None of the patients with chronic HCV infection had clinical or subclinical evidence of dilated cardiomyopathy from history and laboratory findings. None of the patients with dilated cardiomyopathy was positive for antibodies to HCV or viraemic on HCV RNA testing.
Conclusions—The study neither confirms the findings of other investigators, nor indicates a pathogenic link between HCV and dilated cardiomyopathy. For this reason, at least in Greece, testing for HCV in patients with dilated cardiomyopathy or follow up for heart disease in HCV patients appears unnecessary. Genetic or other factors could be the reason for this discrepancy if previously reported associations between HCV and dilated cardiomyopathy or hypertrophic cardiomyopathy were not coincidental.

 Keywords: hepatitis C virus;  idiopathic dilated cardiomyopathy;  polymerase chain reaction

Full Text

The Full Text of this article is available as a PDF (118.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowles N. E., Richardson P. J., Olsen E. G., Archard L. C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1986 May 17;1(8490):1120–1123. doi: 10.1016/s0140-6736(86)91837-4. [DOI] [PubMed] [Google Scholar]
  2. Bowles N. E., Rose M. L., Taylor P., Banner N. R., Morgan-Capner P., Cunningham L., Archard L. C., Yacoub M. H. End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation. 1989 Nov;80(5):1128–1136. doi: 10.1161/01.cir.80.5.1128. [DOI] [PubMed] [Google Scholar]
  3. Bronowicki J. P., Venard V., Botté C., Monhoven N., Gastin I., Choné L., Hudziak H., Rihn B., Delanoë C., LeFaou A. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med. 1997 Jul 24;337(4):237–240. doi: 10.1056/NEJM199707243370404. [DOI] [PubMed] [Google Scholar]
  4. Caforio A. L., Stewart J. T., McKenna W. J. Idiopathic dilated cardiomyopathy. BMJ. 1990 Apr 7;300(6729):890–891. doi: 10.1136/bmj.300.6729.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cochrane H. R., May F. E., Ashcroft T., Dark J. H. Enteroviruses and idiopathic dilated cardiomyopathy. J Pathol. 1991 Feb;163(2):129–131. doi: 10.1002/path.1711630208. [DOI] [PubMed] [Google Scholar]
  6. Dale J. K., Di Bisceglie A. M., Hoofnagle J. H., Straus S. E. Chronic fatigue syndrome: lack of association with hepatitis C virus infection. J Med Virol. 1991 Jun;34(2):119–121. doi: 10.1002/jmv.1890340209. [DOI] [PubMed] [Google Scholar]
  7. Dalekos G. N., Elisaf M. S., Papagalanis N., Tzallas C., Siamopoulos K. C. Elevated interleukin-1 beta in the circulation of patients with essential hypertension before any drug therapy: a pilot study. Eur J Clin Invest. 1996 Oct;26(10):936–939. doi: 10.1111/j.1365-2362.1996.tb02141.x. [DOI] [PubMed] [Google Scholar]
  8. Dalekos G. N., Elisaf M., Bairaktari E., Tsolas O., Siamopoulos K. C. Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? J Lab Clin Med. 1997 Mar;129(3):300–308. doi: 10.1016/s0022-2143(97)90178-5. [DOI] [PubMed] [Google Scholar]
  9. Dalekos G. N., Ringstad J., Savaidis I., Seferiadis K. I., Tsianos E. V. Zinc, copper and immunological markers in the circulation of well nourished patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 1998 Apr;10(4):331–337. doi: 10.1097/00042737-199804000-00010. [DOI] [PubMed] [Google Scholar]
  10. Dalekos G. N., Zervou E., Bourantas K., Tsianos E. V. Viral hepatitides and idiopathic (autoimmune) thrombocytopenic purpura. Is there any relationship? J Hepatol. 1996 Dec;25(6):1000–1001. doi: 10.1016/s0168-8278(96)80310-2. [DOI] [PubMed] [Google Scholar]
  11. Dalekos G. N., Zervou E., Merkouropoulos M. H., Tsianos E. V. Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: low incidence of HCV infection. Eur J Epidemiol. 1996 Feb;12(1):21–25. doi: 10.1007/BF00144423. [DOI] [PubMed] [Google Scholar]
  12. Dalekos G. N., Zervou E., Tsianos E. V. IgM antibodies to hepatitis C virus in chronic active hepatitis C in NW Greece. Solution or more questions? J Hepatol. 1995 Apr;22(4):509–509. doi: 10.1016/0168-8278(95)80119-7. [DOI] [PubMed] [Google Scholar]
  13. Dec G. W., Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994 Dec 8;331(23):1564–1575. doi: 10.1056/NEJM199412083312307. [DOI] [PubMed] [Google Scholar]
  14. Esteban J. I., Gómez J., Martell M., Cabot B., Quer J., Camps J., González A., Otero T., Moya A., Esteban R. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med. 1996 Feb 29;334(9):555–560. doi: 10.1056/NEJM199602293340902. [DOI] [PubMed] [Google Scholar]
  15. Féray C., Gigou M., Samuel D., Reyes G., Bernuau J., Reynes M., Bismuth H., Bréchot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 1993 Feb;104(2):549–555. doi: 10.1016/0016-5085(93)90425-c. [DOI] [PubMed] [Google Scholar]
  16. Giacca M., Severini G. M., Mestroni L., Salvi A., Lardieri G., Falaschi A., Camerini F. Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994 Oct;24(4):1033–1040. doi: 10.1016/0735-1097(94)90866-4. [DOI] [PubMed] [Google Scholar]
  17. Grasso M., Arbustini E., Silini E., Diegoli M., Percivalle E., Ratti G., Bramerio M., Gavazzi A., Vigano M., Milanesi G. Search for Coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol. 1992 Mar 1;69(6):658–664. doi: 10.1016/0002-9149(92)90160-z. [DOI] [PubMed] [Google Scholar]
  18. Henry W. L., Gardin J. M., Ware J. H. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980 Nov;62(5):1054–1061. doi: 10.1161/01.cir.62.5.1054. [DOI] [PubMed] [Google Scholar]
  19. Imberti L., Cariani E., Bettinardi A., Zonaro A., Albertini A., Primi D. An immunoassay for specific amplified HCV sequences. J Virol Methods. 1991 Oct;34(3):233–243. doi: 10.1016/0166-0934(91)90103-7. [DOI] [PubMed] [Google Scholar]
  20. Jin O., Sole M. J., Butany J. W., Chia W. K., McLaughlin P. R., Liu P., Liew C. C. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation. 1990 Jul;82(1):8–16. doi: 10.1161/01.cir.82.1.8. [DOI] [PubMed] [Google Scholar]
  21. Keeling P. J., Jeffery S., Caforio A. L., Taylor R., Bottazzo G. F., Davies M. J., McKenna W. J. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br Heart J. 1992 Dec;68(6):554–559. doi: 10.1136/hrt.68.12.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kelly D. P., Strauss A. W. Inherited cardiomyopathies. N Engl J Med. 1994 Mar 31;330(13):913–919. doi: 10.1056/NEJM199403313301308. [DOI] [PubMed] [Google Scholar]
  23. Kiyosawa K., Tanaka E., Sodeyama T., Yoshizawa K., Yabu K., Furuta K., Imai H., Nakano Y., Usuda S., Uemura K. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology. 1994 Jun;106(6):1596–1602. doi: 10.1016/0016-5085(94)90416-2. [DOI] [PubMed] [Google Scholar]
  24. Liang T. J., Jeffers L., Reddy R. K., Silva M. O., Cheinquer H., Findor A., De Medina M., Yarbough P. O., Reyes G. R., Schiff E. R. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology. 1993 Feb;104(2):556–562. doi: 10.1016/0016-5085(93)90426-d. [DOI] [PubMed] [Google Scholar]
  25. Manolio T. A., Baughman K. L., Rodeheffer R., Pearson T. A., Bristow J. D., Michels V. V., Abelmann W. H., Harlan W. R. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol. 1992 Jun 1;69(17):1458–1466. doi: 10.1016/0002-9149(92)90901-a. [DOI] [PubMed] [Google Scholar]
  26. Mantero G., Zonaro A., Albertini A., Bertolo P., Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem. 1991 Mar;37(3):422–429. [PubMed] [Google Scholar]
  27. Martin A. B., Webber S., Fricker F. J., Jaffe R., Demmler G., Kearney D., Zhang Y. H., Bodurtha J., Gelb B., Ni J. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994 Jul;90(1):330–339. doi: 10.1161/01.cir.90.1.330. [DOI] [PubMed] [Google Scholar]
  28. Matsumori A., Matoba Y., Nishio R., Shioi T., Ono K., Sasayama S. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 1996 May 24;222(3):678–682. doi: 10.1006/bbrc.1996.0803. [DOI] [PubMed] [Google Scholar]
  29. Matsumori A., Matoba Y., Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation. 1995 Nov 1;92(9):2519–2525. doi: 10.1161/01.cir.92.9.2519. [DOI] [PubMed] [Google Scholar]
  30. Olinde K. D., O'Connell J. B. Inflammatory heart disease: pathogenesis, clinical manifestations, and treatment of myocarditis. Annu Rev Med. 1994;45:481–490. doi: 10.1146/annurev.med.45.1.481. [DOI] [PubMed] [Google Scholar]
  31. Pawlotsky J. M., Bouvier M., Fromont P., Deforges L., Duval J., Dhumeaux D., Bierling P. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol. 1995 Dec;23(6):635–639. doi: 10.1016/0168-8278(95)80027-1. [DOI] [PubMed] [Google Scholar]
  32. Prieto J., Yuste J. R., Beloqui O., Civeira M. P., Riezu J. I., Aguirre B., Sangro B. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996 Feb;23(2):199–204. doi: 10.1002/hep.510230201. [DOI] [PubMed] [Google Scholar]
  33. Puoti M., Zonaro A., Ravaggi A., Marin M. G., Castelnuovo F., Cariani E. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology. 1992 Oct;16(4):877–881. doi: 10.1002/hep.1840160404. [DOI] [PubMed] [Google Scholar]
  34. Quint L., Deny P., Guillevin L., Granger B., Jarrousse B., Lhote F., Scavizzi M. Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol. 1991 May-Jun;9(3):253–257. [PubMed] [Google Scholar]
  35. Ravaggi A., Primi D., Cariani E. Direct PCR amplification of HCV RNA from human serum. PCR Methods Appl. 1992 May;1(4):291–292. doi: 10.1101/gr.1.4.291. [DOI] [PubMed] [Google Scholar]
  36. Reilly J. M., Cunnion R. E., Anderson D. W., O'Leary T. J., Simmons J. T., Lane H. C., Fauci A. S., Roberts W. C., Virmani R., Parrillo J. E. Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. Am J Cardiol. 1988 Oct 1;62(10 Pt 1):789–793. doi: 10.1016/0002-9149(88)91223-4. [DOI] [PubMed] [Google Scholar]
  37. Sakamoto M., Hirohashi S., Tsuda H., Ino Y., Shimosato Y., Yamasaki S., Makuuchi M., Hasegawa H., Terada M., Hosoda Y. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res. 1988 Dec 15;48(24 Pt 1):7294–7297. [PubMed] [Google Scholar]
  38. Sallie R., Silva A. E., Purdy M., Smith H., McCaustland K., Tibbs C., Portmann B., Eddleston A., Bradley D., Williams R. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 1994 May;20(5):580–588. doi: 10.1016/s0168-8278(05)80343-5. [DOI] [PubMed] [Google Scholar]
  39. Tsianos E. V., Masalas C. N., Merkouropoulos M., Dalekos G. N., Logan R. F. Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common. Gut. 1994 Mar;35(3):369–372. doi: 10.1136/gut.35.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiss L. M., Movahed L. A., Billingham M. E., Cleary M. L. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol. 1991 Feb;138(2):497–503. [PMC free article] [PubMed] [Google Scholar]
  41. Why H. J., Meany B. T., Richardson P. J., Olsen E. G., Bowles N. E., Cunningham L., Freeke C. A., Archard L. C. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994 Jun;89(6):2582–2589. doi: 10.1161/01.cir.89.6.2582. [DOI] [PubMed] [Google Scholar]
  42. Wilson S. E., Lee W. M., Murakami C., Weng J., Moninger G. A. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology. 1994 Apr;101(4):736–745. doi: 10.1016/s0161-6420(94)31291-7. [DOI] [PubMed] [Google Scholar]
  43. Yanagi M., Kaneko S., Unoura M., Murakami S., Kobayashi K., Sugihara J., Ohnishi H., Muto Y. Hepatitis C virus in fulminant hepatic failure. N Engl J Med. 1991 Jun 27;324(26):1895–1896. doi: 10.1056/NEJM199106273242615. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES